|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Expression analysis of peptide growth factors VEGF,FGF2,TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia显示文摘 | Soulitzis N Karyotis I Delakas D | 2006 | Int J Oncol2006，29，2： | 1 |
| 2 | Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes显示文摘 | Papadakis ED Soulitzis N Spandidos D A | 2002 | Br J Cancer2002，87，9： | 1 |
| 3 | p53 codon 72 polymorphism and its association with bladder cancer显示文摘 | Sourvinos G Dokianakis D N | 2002 | Cancer Lett2002，179，2： | 1 |
| 4 | Expression analysis of B - Raf oncogene in V600E - negative benign and malignant tumors of the thyroid gland : correlation with late disease onset 显示文摘 | Derdas S P Soulitzis N Balis V | 2013 | Medical Oncology2013，30，1： | 1 |
| 5 | Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence 显示文摘 | Papadogianni D Soulitzis N Delakas D | 2014 | Tumour Biol2014，35，： | 1 |
| 6 | Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer:potential clinical applications显示文摘 | Guan M Zhou X Soulitzis N | 2006 | Clin Cancer Res2006，12，5： | 1 |
| 7 | Expression analysis of peptide growth factors VEGF, FGF2, TGFβ1, EGF and IGFI in prostate cancer and benign prostatic hyperplasia 显示文摘 | Soulitzis N Karyotis I Delakas D | 2006 | Int J Oncol2006，29，2： | 1 |
| 8 | Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumors arising in Arg/Pro germline heterozygote显示文摘 | Papadakis E D Soulitzis N Spandidos D A | 2002 | Br J Cancer2002，87，9： | 1 |
| 9 | Expression analysis of peptide growth factors VEGF,FGF2,TGFB1,EGF and IGF1 in prostate cancer and benign prostatic hyperplasia显示文摘 | Soulitzis N Karyotis I Delakas D | 2006 | Int J Oncol2006，29，2： | 1 |
| 10 | p53 codon 72polymorphism and its association with bladder cancer 显示文摘 | Sourvinos G Dokianakis DN | 2002 | Cancer Lett2002，179，： | 1 |
| 11 | Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications 显示文摘 | Guan M Zhou X Soulitzis N | 2006 | Clin Cancer Res2006，12，5： | 1 |
| 12 | Granule cytotoxic activity and oxidative DNA damage in smoking and nonsmoking patients with asthma显示文摘 | Proklou A Soulitzis N Neofytou EA | 2013 | Chest2013，144，4： | 1 |
| 13 | Aberrant Methylation and Deacetylation of Deleted in liver cancer-1 Gene in Prostate Cancer:Potential Clinical Applications显示文摘 | Guan M Zhou X Soulitzis N | 2006 | Clin Cancer Res2006，12，5： | 1 |
| 14 | Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications显示文摘 | Guan M Zhou X Soulitzis N | 2006 | Clin Cancer Res2006，12，5： | 1 |
| 15 | Expression analysis of peptide growth factors VEGF,FGF2,TGFB1,EGF and IGF1 in prostate cancer and benign prostatic hyperplasia显示文摘 | Soulitzis N Karyotis I Delakas D | 2006 | Int J Oncol2006，29，2： | 1 |
| 16 | Aberrant methylation and deacetylation of deleted in liver cancer-I gene in prostate cancer: potential clinical applications 显示文摘 | Guan M Zhou X Soulitzis N | 2006 | Clin Cancer Res2006，12，5： | 1 |
| 17 | Downregulation of Notch signaling pathway in late preterm and term placentas from pregnancies complicated by preeclampsia显示文摘 | Fragkiadaki P Soulitzis N Sifakis S | 2015 | PLoS One2015，10，01： | 1 |
| 18 | Downregulation of lung mitochondrial prohibitin in COPD显示文摘 | SOULITZIS N NEOFYTOU E PSARROU M | 2012 | Respir Med2012，106，7： | 1 |
| 19 | Aberrant methylation and deaeetylation of deleted in liver cancer-1 gene in prostate cancer:potential clinical applications显示文摘 | GUAN M ZHOU X SOULITZIS N | 2006 | Clin Cancer Res2006，12，： | 1 |
| 20 | Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: po- tential clinical applications 显示文摘 | Guan M Zhou X Soulitzis N | 2006 | Clin Cancer Res2006，12，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员